A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO
- PMID: 8574810
A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO
Abstract
A new method for the labelling of mixed leucocytes with 99mTc-tropolone was optimized and compared with a 99mTc-HMPAO leucocyte labelling procedure in vitro and in vivo. In the present study, leucocytes obtained from patients suffering from Crohn's disease, were isolated and labelled with 99mTc-HMPAO or labelled according the new 99mTc-tropolone procedure using 9.8 mM tropolone, 1 microM stannous chloride and 0.8 mM potassium borohydride (KBH4) at pH 5.5-6. Labelling efficiency with 99mTc-tropolone yielded 92 +/- 3%, which is higher compared to the 99mTc-HMPAO labelling procedure (64 +/- 13%) using 10(8) of leucocytes. In vitro stability and viability of both the tropolone and the HMPAO labelled cells was investigated. The viability test of the 99mTc-labelled leucocytes was performed in autologous plasma at 37 degrees C and compared with unlabelled leucocytes. After 18 hours of incubation a significant (P < 0.05) higher stability was observed for 99mTc-tropolone labelled leucocytes (84 +/- 5%) compared with that of 99mTc-HMPAO labelled leucocytes (73 +/- 5%). The viability of the 99mTc-labelled leucocytes observed for both labelling procedures was similar to unlabelled leucocytes. In vivo experiments were performed in mice. 99mTc-tropolone or 99mTc-HMPAO labelled murine mixed leucocytes were injected in mice, with a Staphylococcus aureus ATCC 25923 thigh infection. Analysis of scintigraphic images yielded a faster clearance of the 99mTc-tropolone labelled leucocytes. This was most likely due to a significant (P < 0.02) higher liver uptake at 4 hours after administration of the 99mTc-tropolone labelled leucocytes (19%) in comparison with 99mTc-HMPAO labelled cells (9%). Faster and significant (P < 0.02) higher accumulation of the 99mTc-tropolone labelled leucocytes was observed at the site of infection compared with 99mTc-HMPAO labelled leucocytes at all time-intervals after the administration of the 99mTc-labelled leucocytes. The new 99mTc-tropolone leucocyte labelling procedure, offers an attractive low-cost agent for research purposes.
Similar articles
-
An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.Q J Nucl Med Mol Imaging. 2004 Sep;48(3):229-36. Q J Nucl Med Mol Imaging. 2004. PMID: 15499297
-
Labelling of leukocytes with 99mTc-HMPAO for scintigraphy of inflammatory lesions and abscesses.Int J Rad Appl Instrum B. 1992 Apr;19(3):251-6. doi: 10.1016/0883-2897(92)90107-a. Int J Rad Appl Instrum B. 1992. PMID: 1629013
-
In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.Eur J Nucl Med. 1990;16(4-6):299-302. doi: 10.1007/BF00842783. Eur J Nucl Med. 1990. PMID: 2161770
-
Imaging of abdominal inflammation using other radioisotope techniques.Scand J Gastroenterol Suppl. 1994;203:48-54. doi: 10.3109/00365529409091397. Scand J Gastroenterol Suppl. 1994. PMID: 7973449 Review.
-
Background subtraction: a new approach to the assessment of disease activity in Crohn's disease using 99mTc-HMPAO-labelled leucocytes.Scand J Gastroenterol Suppl. 1994;203:55-60. doi: 10.3109/00365529409091398. Scand J Gastroenterol Suppl. 1994. PMID: 7973451 Review.
Cited by
-
In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear Medicine.Stem Cells Int. 2016;2016:3140120. doi: 10.1155/2016/3140120. Epub 2016 Jan 12. Stem Cells Int. 2016. PMID: 26880951 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases